How severe is CVE-2026-32921?

CVE-2026-32921 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.

Is CVE-2026-32921 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2026-32921?

CVE-2026-32921 affects Openclaw. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2026-32921?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2026-32921 have an EU (EUVD) identifier?

Yes. CVE-2026-32921 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-17375.

When was CVE-2026-32921 published?

CVE-2026-32921 was published on 2026-03-31 and last updated on 2026-06-17.

CVE-2026-32921

CVE-2026-32921 is a medium-severity vulnerability in Openclaw with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-367.

Key facts

Severity: Medium (CVSS 3.x base score 6.3)
CVSS v4: 5.3
EPSS exploit prediction: 0% (10th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2026-17375
Weakness: CWE-367
Affected product: Openclaw
Published: 2026-03-31
Last modified: 2026-06-17

Description

OpenClaw before 2026.3.8 contains an approval bypass vulnerability in system.run where mutable script operands are not bound across approval and execution phases. Attackers can obtain approval for script execution, modify the approved script file before execution, and execute different content while maintaining the same approved command shape.

Frequently asked questions

What is CVE-2026-32921?: OpenClaw before 2026.3.8 contains an approval bypass vulnerability in system.run where mutable script operands are not bound across approval and execution phases. Attackers can obtain approval for script execution, modify the approved script file before execution, and execute different content while maintaining the same approved command shape.
How severe is CVE-2026-32921?: CVE-2026-32921 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2026-32921 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (10th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2026-32921?: CVE-2026-32921 affects Openclaw. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2026-32921?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2026-32921 have an EU (EUVD) identifier?: Yes. CVE-2026-32921 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2026-17375.
When was CVE-2026-32921 published?: CVE-2026-32921 was published on 2026-03-31 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:openclaw:openclaw:*:*:*:*:*:node.js:*:*

More vulnerabilities in Openclaw

CVE-2026-41329 — Critical (CVSS 9.9): OpenClaw before 2026.3.31 contains a sandbox bypass vulnerability allowing attackers to escalate privileges via…
CVE-2026-33579 — Critical (CVSS 9.9): OpenClaw before 2026.3.28 contains a privilege escalation vulnerability in the /pair approve command path that fails to…
CVE-2026-32922 — Critical (CVSS 9.9): OpenClaw before 2026.3.11 contains a privilege escalation vulnerability in device.token.rotate that allows callers with…
CVE-2026-22172 — Critical (CVSS 9.9): OpenClaw versions prior to 2026.3.12 contain an authorization bypass vulnerability in the WebSocket connect path that…
CVE-2026-28466 — Critical (CVSS 9.9): OpenClaw versions prior to 2026.2.14 contain a vulnerability in the gateway in which it fails to sanitize internal…
CVE-2026-28363 — Critical (CVSS 9.9): In OpenClaw before 2026.2.23, tools.exec.safeBins validation for sort could be bypassed via GNU long-option…

All CVEs affecting Openclaw →

Other CWE-367 (Time-of-check Time-of-use (TOCTOU) Race Condition) vulnerabilities

CVE-2026-25641 — Critical (CVSS 10.0): SandboxJS is a JavaScript sandboxing library. Prior to 0.8.29, there is a sandbox escape vulnerability due to a…
CVE-2025-64180 — Critical (CVSS 10.0): Manager-io/Manager is accounting software. In Manager Desktop and Server versions 25.11.1.3085 and below, a critical…
CVE-2025-34027 — Critical (CVSS 10.0): The Versa Concerto SD-WAN orchestration platform is vulnerable to an authentication bypass in the Traefik reverse proxy…
CVE-2026-25052 — Critical (CVSS 9.9): n8n is an open source workflow automation platform. Prior to versions 1.123.18 and 2.5.0, a vulnerability in the file…
CVE-2025-13032 — Critical (CVSS 9.9): Double fetch in sandbox kernel driver in Avast/AVG Antivirus <25.3 on windows allows local attacker to escalate…
CVE-2026-53838 — Critical (CVSS 9.8): OpenClaw before 2026.5.27 contains a state mutation vulnerability in node pairing reconnection that allows paired nodes…

Browse all CWE-367 (Time-of-check Time-of-use (TOCTOU) Race Condition) vulnerabilities →